YS Biopharma (YSBPW) Competitors $0.04 0.00 (0.00%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrends YSBPW vs. ATNFW, SXTPW, DRTSW, WENAW, APLMW, BCTXW, CDIOW, CTCXW, CELUW, and CEROWShould you be buying YS Biopharma stock or one of its competitors? The main competitors of YS Biopharma include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Celularity (CELUW), and CERo Therapeutics (CEROW). These companies are all part of the "biotechnology" industry. YS Biopharma vs. 180 Life Sciences 60 Degrees Pharmaceuticals Alpha Tau Medical Anew Medical Apollomics BriaCell Therapeutics Cardio Diagnostics Carmell Celularity CERo Therapeutics 180 Life Sciences (NASDAQ:ATNFW) and YS Biopharma (NASDAQ:YSBPW) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, community ranking, dividends, risk, media sentiment, institutional ownership, earnings, profitability and analyst recommendations. Which has higher valuation and earnings, ATNFW or YSBPW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/AYS Biopharma$560.76MN/AN/AN/AN/A Does the MarketBeat Community prefer ATNFW or YSBPW? 180 Life Sciences and YS Biopharma both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperform180 Life SciencesN/AN/AYS BiopharmaN/AN/A Is ATNFW or YSBPW more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A YS Biopharma N/A N/A N/A Does the media prefer ATNFW or YSBPW? In the previous week, 180 Life Sciences had 1 more articles in the media than YS Biopharma. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for YS Biopharma. 180 Life Sciences' average media sentiment score of 1.87 beat YS Biopharma's score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the media. Company Overall Sentiment 180 Life Sciences Very Positive YS Biopharma Neutral Summary180 Life Sciences beats YS Biopharma on 2 of the 3 factors compared between the two stocks. Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get YS Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for YSBPW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart YSBPW vs. The Competition Export to ExcelMetricYS BiopharmaBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$146.98M$5.07B$8.68BDividend YieldN/A3.56%5.05%4.06%P/E RatioN/A186.5999.7117.25Price / SalesN/A15,604.011,236.4985.68Price / CashN/A12.0340.5836.40Price / BookN/A7.366.325.86Net IncomeN/A-$19.86M$119.47M$225.66M7 Day PerformanceN/A7.57%-4.09%-0.68%1 Month PerformanceN/A10.47%-2.15%1.65%1 Year PerformanceN/A30.45%33.16%25.72% YS Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)YSBPWYS BiopharmaN/A$0.04flatN/A+125.8%$0.00$560.76M0.00865ATNFW180 Life SciencesN/A$0.01flatN/A-19.0%$0.00N/A0.007Positive NewsGap DownSXTPW60 Degrees PharmaceuticalsN/A$0.04+114.3%N/A-26.0%$0.00$418,304.000.002Positive NewsDRTSWAlpha Tau MedicalN/A$0.17-14.9%N/A-37.3%$0.00N/A0.0080News CoverageWENAWAnew MedicalN/A$0.04-0.3%N/AN/A$0.00N/A0.00N/AGap DownAPLMWApollomicsN/A$0.01flatN/A-72.3%$0.00N/A0.0059Short Interest ↓Positive NewsGap DownBCTXWBriaCell TherapeuticsN/A$0.29+7.4%N/A-83.6%$0.00N/A0.008Short Interest ↓Positive NewsGap DownCDIOWCardio DiagnosticsN/A$0.04flatN/A-63.6%$0.00$39,138.000.007Positive NewsGap UpCTCXWCarmellN/A$0.11flatN/AN/A$0.00$12,320.000.009Positive NewsCELUWCelularityN/A$0.02flatN/A+64.5%$0.00$42.69M0.00220Positive NewsGap UpCEROWCERo TherapeuticsN/A$0.01-57.5%N/AN/A$0.00N/A0.008Short Interest ↓Positive NewsGap Down Related Companies and Tools Related Companies 180 Life Sciences Alternatives 60 Degrees Pharmaceuticals Alternatives Alpha Tau Medical Alternatives Anew Medical Alternatives Apollomics Alternatives BriaCell Therapeutics Alternatives Cardio Diagnostics Alternatives Carmell Alternatives Celularity Alternatives CERo Therapeutics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:YSBPW) was last updated on 11/16/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | SponsoredBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of...Golden Crest | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredWatch this before it gets removed If you missed it, my emergency election broadcast is now available - but will be removed soonPorter & Company | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this BEFORE November 19th.Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding YS Biopharma Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share YS Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free YSBPW Stock Alerts